4D Molecular Therapeutics, Inc. Increase (Decrease) in Derivative Liabilities
4D Molecular Therapeutics, Inc. (FDMT) reported Increase (Decrease) in Derivative Liabilities of $26.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDerivativeLiabilities · last filed 2026-08-13
- 4D Molecular Therapeutics, Inc. increase (decrease) in derivative liabilities for the quarter ending 2026-06-30 was $14.00K, a 16.67% increase year-over-year.
- 4D Molecular Therapeutics, Inc. increase (decrease) in derivative liabilities for the quarter ending 2026-03-31 was $12.00K.
- 4D Molecular Therapeutics, Inc. increase (decrease) in derivative liabilities for the quarter ending 2025-12-31 was $13.00K, a 7.14% decline year-over-year.
- 4D Molecular Therapeutics, Inc. increase (decrease) in derivative liabilities for the quarter ending 2025-09-30 was $11.00K, a 21.43% decline year-over-year.
- 4D Molecular Therapeutics, Inc. increase (decrease) in derivative liabilities for fiscal 2025 was -$52.00K, a 226.83% decline from fiscal 2024.
- 4D Molecular Therapeutics, Inc. increase (decrease) in derivative liabilities for fiscal 2024 was $41.00K, a 73.89% decline from fiscal 2023.
- 4D Molecular Therapeutics, Inc. increase (decrease) in derivative liabilities for fiscal 2023 was $157.00K.
- 4D Molecular Therapeutics, Inc. increase (decrease) in derivative liabilities for fiscal 2022 was -$2.00K, a 102.17% decline from fiscal 2021.
| Period end | Increase (Decrease) in Derivative Liabilities 3 month | Increase (Decrease) in Derivative Liabilities 6 month | Increase (Decrease) in Derivative Liabilities 9 month | Increase (Decrease) in Derivative Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $26.00K 10-Q · filed 2026-08-13 | $39.00K derived: sum of 3 quarters · filed 2026-08-13 | $50.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $12.00K 10-Q · filed 2026-05-07 | $25.00K derived: sum of 2 quarters · filed 2026-05-07 | $36.00K derived: sum of 3 quarters · filed 2026-05-07 | $48.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $24.00K derived: sum of 2 quarters · filed 2026-03-18 | $36.00K derived: sum of 3 quarters · filed 2026-08-13 | -$52.00K 10-K · filed 2026-03-18 |
| 2025-09-30 | $11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $23.00K derived: sum of 2 quarters · filed 2026-08-13 | -$65.00K 10-Q · filed 2025-11-10 | -$51.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$76.00K 10-Q · filed 2026-08-13 | -$62.00K derived: sum of 3 quarters · filed 2026-08-13 | -$48.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$88.00K 10-Q · filed 2026-05-07 | -$74.00K derived: sum of 2 quarters · filed 2026-05-07 | -$60.00K derived: sum of 3 quarters · filed 2026-05-07 | -$47.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $28.00K derived: sum of 2 quarters · filed 2026-03-18 | $41.00K derived: sum of 3 quarters · filed 2026-03-18 | $41.00K 10-K · filed 2026-03-18 |
| 2024-09-30 | $14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $27.00K derived: sum of 2 quarters · filed 2025-11-10 | $27.00K 10-Q · filed 2025-11-10 | $27.00K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $13.00K 10-Q · filed 2025-08-11 | $13.00K derived: sum of 3 quarters · filed 2025-08-11 | $170.00K derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-09 | $0.00 derived: sum of 2 quarters · filed 2025-02-28 | $157.00K derived: sum of 3 quarters · filed 2025-02-28 | $150.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $157.00K derived: sum of 2 quarters · filed 2025-02-28 | $150.00K derived: sum of 3 quarters · filed 2025-02-28 | $157.00K 10-K · filed 2025-02-28 |
| 2023-09-30 | $157.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $150.00K derived: sum of 2 quarters · filed 2024-11-13 | $157.00K 10-Q · filed 2024-11-13 | $156.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | -$7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | -$1.00K derived: sum of 3 quarters · filed 2024-08-08 | -$10.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $7.00K 10-Q · filed 2024-05-09 | $6.00K derived: sum of 2 quarters · filed 2024-05-09 | -$3.00K derived: sum of 3 quarters · filed 2024-05-09 | -$2.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$10.00K derived: sum of 2 quarters · filed 2024-02-29 | -$9.00K derived: sum of 3 quarters · filed 2024-02-29 | -$2.00K 10-K · filed 2024-02-29 |
| 2022-09-30 | -$9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$8.00K derived: sum of 2 quarters · filed 2023-11-09 | -$1.00K 10-Q · filed 2023-11-09 | -$1.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $8.00K 10-Q · filed 2023-08-09 | $8.00K derived: sum of 3 quarters · filed 2023-08-09 | $15.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $7.00K 10-Q · filed 2023-05-11 | $7.00K derived: sum of 2 quarters · filed 2023-05-11 | $14.00K derived: sum of 3 quarters · filed 2023-05-11 | $7.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $7.00K derived: sum of 2 quarters · filed 2023-03-15 | $0.00 derived: sum of 3 quarters · filed 2023-03-15 | $92.00K 10-K · filed 2023-03-15 |
| 2021-09-30 | $7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $92.00K 10-Q · filed 2022-11-08 | $97.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | -$7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $85.00K 10-Q · filed 2022-08-11 | $90.00K derived: sum of 3 quarters · filed 2022-08-11 | $95.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $92.00K 10-Q · filed 2022-05-12 | $97.00K derived: sum of 2 quarters · filed 2022-05-12 | $102.00K derived: sum of 3 quarters · filed 2022-05-12 | $100.00K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $10.00K derived: sum of 2 quarters · filed 2022-03-28 | $8.00K derived: sum of 3 quarters · filed 2022-03-28 | $21.00K 10-K · filed 2022-03-28 |
| 2020-09-30 | $5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $3.00K derived: sum of 2 quarters · filed 2021-11-10 | $16.00K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | -$2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $11.00K 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $13.00K 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | $37.00K 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Entera Bio Ltd. (ENTX) | $0.485B |